Impact of Hyperoxia During Cardiopulmonary

• Status: Completed
• Trial end date: 2019-03-30
• Target enrollment: 0
• Participant gender: All

Summary

The hypothesis implies that this work is the use of hyperoxia during cardiopulmonary bypass by his heart preconditioning effect is associated with a lower incidence of cardiac arrhythmias (atrial fibrillation, tachycardia or ventricular fibrillation) and lesions of myocardial ischemia-reperfusion injury in cardiac surgery postoperative.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Universitaire, Amiens

Criteria

Inclusion Criteria:

• Major patient ≥ 18 years

• Patient operated cardiac surgery for myocardial revascularization (CABG) or surgical correction of valvular or combined surgery (CABG and valve disease) or ascending aortic surgery

• Signed Consent

• Affiliation to social security

Exclusion Criteria:

• Permanent atrial fibrillation

• Cordarone therapy,

• Pregnant woman

• Patient under guardianship or trusteeship or private public law

• Internal pacemaker

• Hypothermia,

• Patient refusal,

• Cardiac surgery without extracorporal circulation (ECC),

• Participation in another study.